Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1582-1614
Closed Access | Times Cited: 8

Showing 8 citing articles:

Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, et al.
Journal of Molecular Structure (2025) Vol. 1327, pp. 141227-141227
Closed Access
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure–activity relationship
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das, et al.
Molecular Diversity (2025)
Closed Access
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 14
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 7
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure‐Activity Relationship
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 5
Efficient synthetic strategies for fused pyrimidine and pyridine derivatives: A review
Sharmil N. Anjirwala, Saurabh K. Patel
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 10, pp. 1481-1516
Closed Access | Times Cited: 1
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
Ketan R Hosamani, K. Hemalatha, Rohit Pal, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Closed Access | Times Cited: 1
The Protective Potential of Butyrate against Colon Cancer Cell Migration and Invasion Is Critically Dependent on Cell Type
Sema Öncel, Bryan D. Safratowich, Huawei Zeng
Molecular Nutrition & Food Research (2024)
Closed Access
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
Page 1

Scroll to top